Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 220

1.

Identification of distinct circulating exosomes in Parkinson's disease.

Tomlinson PR, Zheng Y, Fischer R, Heidasch R, Gardiner C, Evetts S, Hu M, Wade-Martins R, Turner MR, Morris J, Talbot K, Kessler BM, Tofaris GK.

Ann Clin Transl Neurol. 2015 Apr;2(4):353-61. doi: 10.1002/acn3.175. Epub 2015 Feb 6.

2.

Linking compensation to payment incentives. A new challenge for healthcare.

Seymour D, Talbot KC, Stutelberg C.

Healthc Exec. 2014 Jul-Aug;29(4):58-60. No abstract available.

PMID:
25672112
3.

TARDBP pathogenic mutations increase cytoplasmic translocation of TDP-43 and cause reduction of endoplasmic reticulum Ca²⁺ signaling in motor neurons.

Mutihac R, Alegre-Abarrategui J, Gordon D, Farrimond L, Yamasaki-Mann M, Talbot K, Wade-Martins R.

Neurobiol Dis. 2015 Mar;75:64-77. doi: 10.1016/j.nbd.2014.12.010. Epub 2014 Dec 17.

PMID:
25526708
4.

Oxidative stress reduces levels of dysbindin-1A via its PEST domain.

Yap MY, Lo YL, Talbot K, Ong WY.

Neurochem Int. 2014 Dec;79:65-9. doi: 10.1016/j.neuint.2014.10.001. Epub 2014 Oct 31.

PMID:
25445987
5.

Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS.

Smith BN, Ticozzi N, Fallini C, Gkazi AS, Topp S, Kenna KP, Scotter EL, Kost J, Keagle P, Miller JW, Calini D, Vance C, Danielson EW, Troakes C, Tiloca C, Al-Sarraj S, Lewis EA, King A, Colombrita C, Pensato V, Castellotti B, de Belleroche J, Baas F, ten Asbroek AL, Sapp PC, McKenna-Yasek D, McLaughlin RL, Polak M, Asress S, Esteban-Pérez J, Muñoz-Blanco JL, Simpson M; SLAGEN Consortium, van Rheenen W, Diekstra FP, Lauria G, Duga S, Corti S, Cereda C, Corrado L, Sorarù G, Morrison KE, Williams KL, Nicholson GA, Blair IP, Dion PA, Leblond CS, Rouleau GA, Hardiman O, Veldink JH, van den Berg LH, Al-Chalabi A, Pall H, Shaw PJ, Turner MR, Talbot K, Taroni F, García-Redondo A, Wu Z, Glass JD, Gellera C, Ratti A, Brown RH Jr, Silani V, Shaw CE, Landers JE.

Neuron. 2014 Oct 22;84(2):324-31. doi: 10.1016/j.neuron.2014.09.027. Epub 2014 Oct 22.

PMID:
25374358
6.

Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia.

Banerjee A, Wang HY, Borgmann-Winter KE, MacDonald ML, Kaprielian H, Stucky A, Kvasic J, Egbujo C, Ray R, Talbot K, Hemby SE, Siegel SJ, Arnold SE, Sleiman P, Chang X, Hakonarson H, Gur RE, Hahn CG.

Mol Psychiatry. 2014 Oct 21. doi: 10.1038/mp.2014.115. [Epub ahead of print]

PMID:
25330739
7.

WHAT MAKES US TICK…TOCK?: USING FRUIT FLIES TO STUDY CIRCADIAN RHYTHMS.

Talbot K, Hug B.

Sci Teach. 2013 Dec;80(9):37-43. No abstract available.

8.

Advances in the clinical science of the motor unit: from motor neuron to neuromuscular junction.

Talbot K, Vincent A.

Curr Opin Neurol. 2014 Oct;27(5):503-5. doi: 10.1097/WCO.0000000000000139. No abstract available.

PMID:
25159932
9.

Swallowing and oropharyngeal dysphagia.

Turner MR, Talbot K.

Clin Med. 2014 Aug;14(4):456. doi: 10.7861/clinmedicine.14-4-456a. No abstract available.

PMID:
25099863
10.

Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis.

Menke RA, Körner S, Filippini N, Douaud G, Knight S, Talbot K, Turner MR.

Brain. 2014 Sep;137(Pt 9):2546-55. doi: 10.1093/brain/awu162. Epub 2014 Jun 20.

11.

Event- and time-triggered remembering: the impact of attention deficit hyperactivity disorder on prospective memory performance in children.

Talbot KD, Kerns KA.

J Exp Child Psychol. 2014 Nov;127:126-43. doi: 10.1016/j.jecp.2014.02.011. Epub 2014 Jun 3.

PMID:
24933706
12.

Autosomal dominant inheritance of rapidly progressive amyotrophic lateral sclerosis due to a truncation mutation in the fused in sarcoma (FUS) gene.

Kent L, Vizard TN, Smith BN, Topp SD, Vance C, Gkazi A, Miller J, Shaw CE, Talbot K.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):557-62. doi: 10.3109/21678421.2014.920033. Epub 2014 Jun 5.

PMID:
24899262
13.

Newly identified precipitating factors in mechanical ventilation-induced brain damage: implications for treating ICU delirium.

González-López A, Albaiceta GM, Talbot K.

Expert Rev Neurother. 2014 Jun;14(6):583-8. doi: 10.1586/14737175.2014.915743.

PMID:
24852225
14.

FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion.

Bäumer D, East SZ, Tseu B, Zeman A, Hilton D, Talbot K, Ansorge O.

Acta Neuropathol. 2014 Oct;128(4):597-604. doi: 10.1007/s00401-014-1277-z. Epub 2014 Apr 10.

PMID:
24718895
15.

Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes.

Larimore J, Zlatic SA, Gokhale A, Tornieri K, Singleton KS, Mullin AP, Tang J, Talbot K, Faundez V.

J Biol Chem. 2014 May 16;289(20):14291-300. doi: 10.1074/jbc.M114.553750. Epub 2014 Apr 8.

PMID:
24713699
16.

A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories.

Akimoto C, Volk AE, van Blitterswijk M, Van den Broeck M, Leblond CS, Lumbroso S, Camu W, Neitzel B, Onodera O, van Rheenen W, Pinto S, Weber M, Smith B, Proven M, Talbot K, Keagle P, Chesi A, Ratti A, van der Zee J, Alstermark H, Birve A, Calini D, Nordin A, Tradowsky DC, Just W, Daoud H, Angerbauer S, DeJesus-Hernandez M, Konno T, Lloyd-Jani A, de Carvalho M, Mouzat K, Landers JE, Veldink JH, Silani V, Gitler AD, Shaw CE, Rouleau GA, van den Berg LH, Van Broeckhoven C, Rademakers R, Andersen PM, Kubisch C.

J Med Genet. 2014 Jun;51(6):419-24. doi: 10.1136/jmedgenet-2014-102360. Epub 2014 Apr 4.

17.

Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs.

Talbot K.

Neurodegener Dis Manag. 2014;4(1):31-40. doi: 10.2217/nmt.13.73. Review.

PMID:
24640977
18.

The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.

Talbot K, Wang HY.

Alzheimers Dement. 2014 Feb;10(1 Suppl):S12-25. doi: 10.1016/j.jalz.2013.12.007. Review.

19.

T₂-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS.

Evans MC, Serres S, Khrapitchev AA, Stolp HB, Anthony DC, Talbot K, Turner MR, Sibson NR.

J Cereb Blood Flow Metab. 2014 May;34(5):785-93. doi: 10.1038/jcbfm.2014.19. Epub 2014 Feb 5.

20.

Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning.

Glen WB Jr, Horowitz B, Carlson GC, Cannon TD, Talbot K, Jentsch JD, Lavin A.

Hippocampus. 2014 Feb;24(2):204-13. doi: 10.1002/hipo.22215. Epub 2013 Nov 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk